Live Breaking News & Updates on Disease Recurrence

Stay updated with breaking news from Disease recurrence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oncotype Score Helps Avoid Unnecessary Radiation in DCIS

Using a gene test to guide radiation decisions may reduce overtreatment in ductal carcinoma in situ. ....

Northwestern University , United States , San Antonio , Seema Khan , Ut Health San Antonio , Antonio Breast Cancer , Breast Cancer , Alignant Breast Neoplasm , Breast Carcinoma , Breast Conserving Surgery , Onservative Breast Surgery , Breast Preservation Surgery , Mammary Gland , Alignant Neoplasia , Alignant Neoplasm , Radiation Therapy , Radiation Oncology , Ductal Carcinoma In Situ , Cis Ductal Carcinoma In Situ , Disease Recurrence ,

Pilonidal Disease: Study Finds Laser Hair Removal Beneficial

The study compared laser epilation plus standard of care with standard care alone for patients aged 11-20 years with pilonidal disease. ....

Facial Rejuvenation , Aesthetic Medicine , Skin And Soft Tissue Infection , Laser Hair Removal , Aser Assisted Hair Removal , Pilonidal Disease , Disease Recurrence , Dherence To Medication Issues For Patients , Adolescent Medicine , Young Adult ,

Syndax Announces Updated Data Supporting Impressive Clinical Profile of Revumenib in Genetically-Defined Acute Leukemias to Be Presented at the 65th ASH Annual Meeting

WALTHAM - Syndax Pharmaceuticals , a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that updated data from multiple trials across its. ....

San Diego , United States , Andrius Zuenka , Ghayas Issa , Revumenib Monotherapy , Decitabine Cedazuridine , Sharon Klahre , Michaela Metzger , Ibrahim Aldoss , Drug Administration , Syndax Pharmaceuticals Nasdaq , American Society Of Hematology , Syndax Pharmaceuticals , European Commission , Data Monitoring Committee , Exchange Commission , Oncology Center , Annual Meeting , Chief Executive , Independent Data Monitoring Committee , New Drug Application , Real Time Oncology Review , Acute Leukemias , Safety Results , Myeloid Leukemias , Investigational Therapies ,

FDA Approves Nivolumab for Resected Stage IIB/C Melanoma

The new approval expands the melanoma indication for nivolumab to earlier-stage disease. ....

Bristol Myers Squibb , Drug Administration , Myers Squibb , Malignant Melanoma , Skin Cancer , Alignant Skin Neoplasm , Disease Recurrence , Sentinel Lymph Node , Us Food And Drug Administration , Nited States Food And Drug Administration , Intravenous Iv , Lymph Nodes , Orphan Drugs , Pain Management , Pain Management ,

Pinpointing Key Features of Gut Dysbiosis in Melanoma

Fecal microbiota profiles differ among patients with melanoma and those without as well as between patients with early stage and late-stage disease, new data suggest. ....

United States , Russell Witt , Bristol Myers Squibb , Md Anderson Cancer Center , National Institutes Of Health , Cancer Center , National Institutes , Malignant Melanoma , Skin Cancer , Alignant Skin Neoplasm , Biologic Therapy , Alignant Neoplasia , Disease Recurrence , Physician Assistants ,